Trial Outcomes & Findings for Meditation Interventions for Treatment of PTSD in Veterans (NCT NCT01548742)

NCT ID: NCT01548742

Last Updated: 2015-12-10

Results Overview

The PCL is a valid and reliable measure of PTSD symptoms. Score range from 17-85; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 10 or more points on the PCL.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

116 participants

Primary outcome timeframe

Baseline, Weeks 3, 6, 9 and 17

Results posted on

2015-12-10

Participant Flow

Participants were recruited through flyers posted in targeted clinics and clinical referrals at the Minneapolis VA Medical Center.

Participants completed a 5-hour eligibility and baseline assessment that included a structured clinical interview and self-report measures. Randomization occurred for those meeting study inclusion criteria.

Participant milestones

Participant milestones
Measure
Arm 1: Mindfulness-Based Stress Reduction (MBSR)
Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.
Arm 2: Present-Centered Group Therapy (PCGT)
Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.
Overall Study
STARTED
58
58
Overall Study
COMPLETED
45
54
Overall Study
NOT COMPLETED
13
4

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Meditation Interventions for Treatment of PTSD in Veterans

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Arm 1: Mindfulness-Based Stress Reduction (MBSR)
n=58 Participants
Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.
Arm 2: Present-Centered Group Therapy (PCGT)
n=58 Participants
Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.
Total
n=116 Participants
Total of all reporting groups
Age, Continuous
57.6 years
STANDARD_DEVIATION 10.4 • n=5 Participants
59.4 years
STANDARD_DEVIATION 9.2 • n=7 Participants
58.5 years
STANDARD_DEVIATION 9.8 • n=5 Participants
Sex: Female, Male
Female
12 Participants
n=5 Participants
6 Participants
n=7 Participants
18 Participants
n=5 Participants
Sex: Female, Male
Male
46 Participants
n=5 Participants
52 Participants
n=7 Participants
98 Participants
n=5 Participants
Race/Ethnicity, Customized
White
47 participants
n=5 Participants
50 participants
n=7 Participants
97 participants
n=5 Participants
Race/Ethnicity, Customized
Black
3 participants
n=5 Participants
6 participants
n=7 Participants
9 participants
n=5 Participants
Race/Ethnicity, Customized
Other
2 participants
n=5 Participants
2 participants
n=7 Participants
4 participants
n=5 Participants
Race/Ethnicity, Customized
Mixed
6 participants
n=5 Participants
0 participants
n=7 Participants
6 participants
n=5 Participants
Service Era
OEF/OIF
6 participants
n=5 Participants
5 participants
n=7 Participants
11 participants
n=5 Participants
Service Era
Gulf War
9 participants
n=5 Participants
8 participants
n=7 Participants
17 participants
n=5 Participants
Service Era
Vietnam War
41 participants
n=5 Participants
45 participants
n=7 Participants
86 participants
n=5 Participants
Service Era
Other
2 participants
n=5 Participants
0 participants
n=7 Participants
2 participants
n=5 Participants
Lifetime trauma exposure
7.9 No. of events
STANDARD_DEVIATION 3.3 • n=5 Participants
7.5 No. of events
STANDARD_DEVIATION 3.0 • n=7 Participants
7.7 No. of events
STANDARD_DEVIATION 3.1 • n=5 Participants
Lifetime trauma exposure event type
Combat exposure
39 participants
n=5 Participants
47 participants
n=7 Participants
86 participants
n=5 Participants
Lifetime trauma exposure event type
Sexual trauma
21 participants
n=5 Participants
11 participants
n=7 Participants
32 participants
n=5 Participants
Lifetime trauma exposure event type
Physical assault
39 participants
n=5 Participants
37 participants
n=7 Participants
76 participants
n=5 Participants
Lifetime trauma exposure event type
Disaster exposure
25 participants
n=5 Participants
25 participants
n=7 Participants
50 participants
n=5 Participants
Lifetime trauma exposure event type
Serious accident
38 participants
n=5 Participants
36 participants
n=7 Participants
74 participants
n=5 Participants
Lifetime trauma exposure event type
Life-threatening illness or injury
34 participants
n=5 Participants
33 participants
n=7 Participants
67 participants
n=5 Participants
Lifetime trauma exposure event type
Other traumatic event
55 participants
n=5 Participants
55 participants
n=7 Participants
110 participants
n=5 Participants
PTSD diagnosis
Full PTSD criteria
57 participants
n=5 Participants
56 participants
n=7 Participants
113 participants
n=5 Participants
PTSD diagnosis
Subthreshold PTSD
1 participants
n=5 Participants
2 participants
n=7 Participants
3 participants
n=5 Participants
Comorbid mood disorder
26 participants
n=5 Participants
23 participants
n=7 Participants
49 participants
n=5 Participants
Taking psychotropic medication
51 participants
n=5 Participants
49 participants
n=7 Participants
100 participants
n=5 Participants
Total number of psychotherapy mental health visits
13.2 sessions
STANDARD_DEVIATION 28.3 • n=5 Participants
14.6 sessions
STANDARD_DEVIATION 29.2 • n=7 Participants
13.9 sessions
STANDARD_DEVIATION 28.7 • n=5 Participants
Duration of previous mental health care
69.0 months
STANDARD_DEVIATION 53.3 • n=5 Participants
63.9 months
STANDARD_DEVIATION 45.2 • n=7 Participants
66.5 months
STANDARD_DEVIATION 9.2 • n=5 Participants
Number of participants receiving 8 or more therapy sessions in PTSD or mental health clinics
19 participants
n=5 Participants
24 participants
n=7 Participants
43 participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline, Weeks 3, 6, 9 and 17

Population: Intent to treat population (all participants randomized to treatment).

The PCL is a valid and reliable measure of PTSD symptoms. Score range from 17-85; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 10 or more points on the PCL.

Outcome measures

Outcome measures
Measure
Arm 1: Mindfulness-Based Stress Reduction (MBSR)
n=58 Participants
Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.
Arm 2: Present-Centered Group Therapy (PCGT)
n=58 Participants
Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.
PTSD Symptoms on the PTSD Checklist (PCL) at Baseline, During Treatment, After Treatment and at 2-Month Follow-up
Baseline PCL
63.6 units on a scale
Interval 60.6 to 66.7
58.8 units on a scale
Interval 55.7 to 61.8
PTSD Symptoms on the PTSD Checklist (PCL) at Baseline, During Treatment, After Treatment and at 2-Month Follow-up
Week 3 PCL
63.9 units on a scale
Interval 60.8 to 67.0
61.7 units on a scale
Interval 58.6 to 64.8
PTSD Symptoms on the PTSD Checklist (PCL) at Baseline, During Treatment, After Treatment and at 2-Month Follow-up
Wee 6 PCL
61.3 units on a scale
Interval 58.1 to 64.4
60.7 units on a scale
Interval 57.6 to 63.8
PTSD Symptoms on the PTSD Checklist (PCL) at Baseline, During Treatment, After Treatment and at 2-Month Follow-up
Week 9 PCL
55.7 units on a scale
Interval 52.6 to 58.9
55.8 units on a scale
Interval 52.7 to 58.9
PTSD Symptoms on the PTSD Checklist (PCL) at Baseline, During Treatment, After Treatment and at 2-Month Follow-up
Week 17 PCL
54.4 units on a scale
Interval 51.2 to 57.6
56.0 units on a scale
Interval 52.9 to 59.0

SECONDARY outcome

Timeframe: Baseline, Weeks 9 and 17

Population: Intent to treat population (all participants randomized to treatment).

The CAPS is a valid and reliable measure of PTSD symptom severity. Score range from 0-136; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 10 or more points on the CAPS.

Outcome measures

Outcome measures
Measure
Arm 1: Mindfulness-Based Stress Reduction (MBSR)
n=58 Participants
Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.
Arm 2: Present-Centered Group Therapy (PCGT)
n=58 Participants
Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.
PTSD Symptom Severity on the Clinician Administered PTSD Scale (CAPS) at Baseline, After Treatment, and at 2-Month Follow-up
Baseline CAPS
69.9 units on a scale
Interval 65.0 to 74.8
62.5 units on a scale
Interval 57.6 to 67.4
PTSD Symptom Severity on the Clinician Administered PTSD Scale (CAPS) at Baseline, After Treatment, and at 2-Month Follow-up
Week 9 CAPS
56.3 units on a scale
Interval 51.0 to 61.5
51.7 units on a scale
Interval 46.5 to 56.8
PTSD Symptom Severity on the Clinician Administered PTSD Scale (CAPS) at Baseline, After Treatment, and at 2-Month Follow-up
Week 17 CAPS
49.8 units on a scale
Interval 44.3 to 55.3
50.6 units on a scale
Interval 45.4 to 55.8

SECONDARY outcome

Timeframe: Baseline, Weeks 9 and 17

Population: Intent to treat population (all participants randomized to treatment).

The PHQ-9 is a valid and reliable measure of depression symptom severity. Score range from 0-27; higher scores indicate more severe symptoms. The minimal clinically important difference for self-reported PTSD symptom severity is a reduction of 5 or more points on the PHQ-9.

Outcome measures

Outcome measures
Measure
Arm 1: Mindfulness-Based Stress Reduction (MBSR)
n=58 Participants
Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.
Arm 2: Present-Centered Group Therapy (PCGT)
n=58 Participants
Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.
Depression Symptom Severity on the Patient Health Questionnaire-9 (PHQ-9) at Baseline, After Treatment, and at 2-Month Follow-up
Baseline PHQ-9
15.5 units on a scale
Interval 13.9 to 17.0
14.6 units on a scale
Interval 13.1 to 16.2
Depression Symptom Severity on the Patient Health Questionnaire-9 (PHQ-9) at Baseline, After Treatment, and at 2-Month Follow-up
Week 9 PHQ-9
13.6 units on a scale
Interval 12.0 to 15.1
13.9 units on a scale
Interval 12.3 to 15.4
Depression Symptom Severity on the Patient Health Questionnaire-9 (PHQ-9) at Baseline, After Treatment, and at 2-Month Follow-up
Week 17 PHQ-9
13.3 units on a scale
Interval 11.7 to 15.0
13.8 units on a scale
Interval 12.2 to 15.4

OTHER_PRE_SPECIFIED outcome

Timeframe: Weeks 9 and 17

Population: Intent to treat analysis

% of participants with clinically significant improvement in self-reported PTSD symptoms defined as a reduction of 10 points or more on the PCL.

Outcome measures

Outcome measures
Measure
Arm 1: Mindfulness-Based Stress Reduction (MBSR)
n=58 Participants
Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.
Arm 2: Present-Centered Group Therapy (PCGT)
n=58 Participants
Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.
Clinically Significant Improvement in Self-reported PTSD Symptoms as Measured by the PCL
% responders, Week 9
36.5 percentage clinical responders
Interval 24.0 to 49.0
22.8 percentage clinical responders
Interval 10.9 to 34.7
Clinically Significant Improvement in Self-reported PTSD Symptoms as Measured by the PCL
% responders, Week 17
48.9 percentage clinical responders
Interval 35.1 to 62.8
28.1 percentage clinical responders
Interval 15.5 to 40.6

OTHER_PRE_SPECIFIED outcome

Timeframe: Weeks 9 and 17

Population: Intent to treat analysis

% of participants with clinically significant improvement in interviewer-rated PTSD symptom severity defined as a reduction of 10 points or more on the CAPS.

Outcome measures

Outcome measures
Measure
Arm 1: Mindfulness-Based Stress Reduction (MBSR)
n=58 Participants
Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.
Arm 2: Present-Centered Group Therapy (PCGT)
n=58 Participants
Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.
Clinically Significant Improvement in Clinician Administered PTSD Scale (CAPS)
% responders, Week 9
63.5 percentage clinical responders
Interval 49.8 to 77.1
49.1 percentage clinical responders
Interval 36.1 to 62.1
Clinically Significant Improvement in Clinician Administered PTSD Scale (CAPS)
% responders, Week 17
66.7 percentage clinical responders
Interval 52.1 to 81.2
54.5 percentage clinical responders
Interval 41.4 to 67.7

Adverse Events

Arm 1: Mindfulness-Based Stress Reduction (MBSR)

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm 2: Present-Centered Group Therapy (PCGT)

Serious events: 2 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Arm 1: Mindfulness-Based Stress Reduction (MBSR)
n=58 participants at risk
Mindfulness-Based Stress Reduction (MBSR): Mindfulness Based Stress Reduction (MBSR) is a group based treatment focused on progressive training in mindfulness meditation.
Arm 2: Present-Centered Group Therapy (PCGT)
n=58 participants at risk
Present-Centered Group Therapy (PCGT): Present-Centered Group Therapy (PCGT) is a group therapy focused on current problems.
Psychiatric disorders
Suicide Attempt or worsening of symptoms
1.7%
1/58 • Number of events 1
1.7%
1/58 • Number of events 1
General disorders
Crushed by falling tree
0.00%
0/58
1.7%
1/58 • Number of events 1

Other adverse events

Adverse event data not reported

Additional Information

Kelvin O. Lim, MD (Principal Investigator)

Minneapolis VA Medical Center

Phone: 612-467-3323

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place